Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Thompson Street Capital Partners Acquires Lifespan Biosciences, Inc.
Private Equity

Thompson Street Capital Partners Acquires Lifespan Biosciences, Inc.

by vcaonline.com posted 2months ago 54 views
ST. LOUIS, September 17, 2018-- Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, has partnered with management to acquire Seattle-based LifeSpan Biosciences, Inc., (LSBio). The Company is a founder-led developer and distributer of antibodies and related reagents primarily to the academic and pharmaceutical research markets via its e-commerce platform. Terms of the transaction were not disclosed. LSBio (www.lsbio.com), originally founded as an immunohistochemistry (IHC) services provider in 1995, has evolved to offer a broad range of antibodies, kits, proteins and other biological reagents. The Company’s offerings include proprietary, value-added and third-party products.